Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Reversal of Conscious Sedation and General Anesthesia |
Dose: Intravenous – 0.2 mg Frequency: once, then every 1 minute as needed Note: Administer over 15 seconds. If after 45 seconds no response, administer 0.2 mg again over 1 minute; may repeat at 1 minute intervals; not to exceed 4 doses (1 mg). If resedation occurs, may repeat doses at 20-minute intervals; not to exceed 1 mg/dose or 3 mg/hour. |
|
Indication: Benzodiazepine Overdose |
Dose: Intravenous – 0.2 mg Frequency: once, then every 1 minute as needed Note: Administer over 15-30 seconds. If no response after 30 seconds, administer 0.3 mg over 30 seconds 1 minute later; if no response, repeat dose of 0.5 mg intravenous over 30 seconds at 1-minute intervals to maximum cumulative dose of 3 mg/hour. In the event of resedation, may repeat dose at 20-minute intervals if needed; not to exceed 1 mg (administered as 0.5 mg/minute) administered at any one time and no more than 3 mg/hour. Rarely patient may require titration up to total dose 5 mg; if no response after 5 minutes, sedation unlikely to be secondary to benzodiazepines. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Reversal of Benzodiazepine Sedation |
Dose: Intravenous – 0.01 mg/kg x1 dose Note: administered over 15 seconds |
|
Indication: Reversal of Benzodiazepine Sedation |
Dose: Intravenous – 0.01 mg/kg Frequency: every minute Note: may repeat after 45 seconds; not to exceed 4 doses for a maximum 0.05 mg/kg or 1 mg, whichever is lower |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment |
Dose: Not studied Note: Renal impairment has not been studied. |
Administration
- For IV use only
- Give slowly
Side Effect
- Dizziness (10%)
- Abnormal/blurred vision (3-9%)
- Agitation (3-9%)
- Dyspnea (3-9%)
- Hyperventilation (3-9%)
- Pain at injection site (3-9%)
- Xerostomia (3-9%)
- Diaphoresis (1-3%)
- Emotional lability (1-3%)
- Fatigue (1-3%)
- Headache (1-3%)
- Paresthesia (1-3%)
- Tremor (1-3%)
- Delirium
- Abnormal hearing
- Junctional tachycardia
- Thick tongue
- Tinnitus
- Coldness sensation
- Generalized seizure
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Cyclic Antidepressants (Fluoxetine, Sertraline, Paroxetine, Citalopram, Escitalopram, Venlafaxine, Duloxetine)
|
Toxic effects
|
|
Benzodiazepines (Diazepam, Alprazolam, Lorazepam, Clonazepam, Midazolam)
|
Reverses effects
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Patients receiving benzodiazepines for life-threatening conditions
|
Can trigger severe withdrawal effects
|
|
Severe tricyclic antidepressant intoxication
|
Risk of seizures
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.